Qiu Li

Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study

Zhenggang Ren, Jianming Xu, Yuxian Bai et al. · The Lancet Oncology · 2021 · 1K citations

Hepatology, Bevacizumab Biosimilar, Medicine +8

Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

Jian Zhou, Hui‐Chuan Sun, Zheng Wang et al. · Liver Cancer · 2023 · 389 citations · Full text

Coordinative metabolism of glutamine carbon and nitrogen in proliferating cancer cells under hypoxia

Yuanyuan Wang, Changsen Bai, Yuxia Ruan et al. · Nature Communications · 2019 · 222 citations · Full text

Glutamine Nitrogen, Glutamine Carbon, Redox Biology +21

Steroids and Flavonoids from <i>Physalis alkekengi</i> var. <i>franchetii</i> and Their Inhibitory Effects on Nitric Oxide Production

Qiu Li, Feng Zhao, Zhihu Jiang et al. · Journal of Natural Products · 2008 · 116 citations

Their Inhibitory Effects, Biosynthesis, Nitric Oxide Production +11

Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)

Juxian Sun, Xinyu Bi, Mengchao Wu et al. · Liver Cancer · 2022 · 103 citations · Full text

Pathology, Cirrhosis, Autoimmune Liver Disease +20